--- title: Recent Posts | case study description: case study | --- - [Our Customers and Partners](http://www.congenica.com/our-customers) - [Our Product Portfolio](http://www.congenica.com/congenica-products) - **Inherited Diseases** - [Rare Disease](http://www.congenica.com/congenica-rare-disease) - [Inherited Cancer](http://www.congenica.com/congenica-inherited-cancer) - [Prenatal Health](http://www.congenica.com/congenica-prenatal) - [Carrier Screening](http://www.congenica.com/congenica-carrier-screening) - [Neurodevelopmental Disorders](http://www.congenica.com/congenica-neuro) - **Somatic Oncology** - [Solid Tumours](http://www.congenica.com/congenica-oncology) - **Pathogen** - [Pathogen Surveillance](http://www.congenica.com/congenica-pathogen-surveillance) - [Our Services](http://www.congenica.com/congenica-services) - [Clinical Interpretation Services](http://www.congenica.com/congenica-clinical-interpretation-services) - [Professional Services](http://www.congenica.com/professional-services) - [Customer Support](http://www.congenica.com/customer-support) - [Pharma Services](http://www.congenica.com/pharma-services) - Resources - [Publications](http://www.congenica.com/publications) - [Supporting materials](http://www.congenica.com/resources) - [News](https://blog.congenica.com/) - [Events and webinars](http://www.congenica.com/events-webinars) - [About us](http://www.congenica.com) - [Leadership Team](http://www.congenica.com/leadership) - [Quality](http://www.congenica.com/quality) - [Investors](http://www.congenica.com/investors) - [People and Vacancies](http://www.congenica.com/people) - [Contact us](http://www.congenica.com/contact) Login ##### Please select your location and reference genome: [America - GRCh37](https://us-37.congenica.com/) [America - GRCh38](https://us-38.congenica.com/) [Europe, Middle East, Africa - GRCh37](https://eu-37.congenica.com/) [Europe, Middle East, Africa - GRCh38](https://eu-38.congenica.com/) # Latest News and Blogs ![Webinar highlights of 2021](https://blog.congenica.com/hs-fs/hubfs/Genomics%2c%20epilepsy%20and%20a%20personal%20account%20of%20West%20Syndrome%20(1).png?width=320&height=192&name=Genomics%2c%20epilepsy%20and%20a%20personal%20account%20of%20West%20Syndrome%20(1).png) 12/15/2021 #### [Webinar highlights of 2021](https://blog.congenica.com/webinar-highlights-of-2021) During 2021 Congenica has delivered a range of informative and thought-provoking webinars from experts within Congenica and from our global customer base ![Expanding our understanding of skeletal dysplasia](https://blog.congenica.com/hs-fs/hubfs/Expanding%20our%20understanding%20of%20skeletal%20dysplasia.png?width=320&height=192&name=Expanding%20our%20understanding%20of%20skeletal%20dysplasia.png) 9/30/2021 #### [Expanding our understanding of skeletal dysplasia](https://blog.congenica.com/expanding-our-understanding-of-skeletal-dysplasia) Clinical case study shows how genomic data analysis has expanded our understanding of rare diseases of bone development. ![Accelerating NGS analysis at ESHG 2021](https://blog.congenica.com/hs-fs/hubfs/ESHG%20warp%20up.png?width=320&height=192&name=ESHG%20warp%20up.png) 9/8/2021 #### [Accelerating NGS analysis at ESHG 2021](https://blog.congenica.com/accelerating-ngs-analysis-at-eshg-2021) Congenica content from ESHG including accelerating NGS analysis satellite session and posters on skeletal dysplasia and automation in a rare disease lab. ![Rapid diagnosis of Long QT syndrome protects family from major health risk](https://blog.congenica.com/hs-fs/hubfs/Add%20a%20subheading%20(1).png?width=320&height=192&name=Add%20a%20subheading%20(1).png) 6/30/2021 #### [Rapid diagnosis of Long QT syndrome protects family from major health risk](https://blog.congenica.com/rapid-diagnosis-of-long-qt-syndrome-protects-family-from-major-health-risk) Congenica supports the rapid diagnosis of Long QT syndrome and enables consideration of potentially life-saving interventions for baby and mother. ![Enhanced whole exome analysis enables Veritas Intercontinental to solve more cases](https://blog.congenica.com/hs-fs/hubfs/Congenica%20helps%20Veritas%20Genetics%20serve%20clients%20and%20solve%20clinical%20cases.png?width=320&height=192&name=Congenica%20helps%20Veritas%20Genetics%20serve%20clients%20and%20solve%20clinical%20cases.png) 6/15/2021 #### [Enhanced whole exome analysis enables Veritas Intercontinental to solve more cases](https://blog.congenica.com/congenica-helps-veritas-genetics-serve-clients-solve-clinical-cases) Veritas Genetics partnered with Congenica to improve diagnostic yield & increase the efficiency, throughput and speed of analysis in diagnostic laboratory ##### Congenica is available as a CE Marked IVD clinical decision support platform for clinical diagnostic use for inherited genetic disorders in the UK and EU, Iceland, Lichtenstein, Norway, Switzerland and Turkey. In all other countries, ensuring compliance with relevant local, national and international clinical laboratory regulations is the responsibility of the laboratory. - [Privacy Policy](http://www.congenica.com/privacy-policy) - [Cookie Policy](http://www.congenica.com/cookie-policy) Log in to Congenica ##### Please select your location and reference genome: [America - GRCh37](https://us-37.congenica.com/) [America - GRCh38](https://us-38.congenica.com/) [Europe, Middle East, Africa - GRCh37](https://eu-37.congenica.com/) [Europe, Middle East, Africa - GRCh38](https://eu-38.congenica.com/) ![CE](https://blog.congenica.com/hs-fs/hubfs/CE.png?width=80&height=80&name=CE.png) ![ISO-27001](https://blog.congenica.com/hs-fs/hubfs/ISO-27001.jpg?width=80&height=80&name=ISO-27001.jpg) ![TR-Testmark_9000030872_EN_2024_CMYK](https://blog.congenica.com/hs-fs/hubfs/2023%20website%20images/TR-Testmark_9000030872_EN_2024_CMYK.png?width=80&height=80&name=TR-Testmark_9000030872_EN_2024_CMYK.png) ![HIPAA Compliant](https://blog.congenica.com/hs-fs/hubfs/HIPAA%20Compliant.png?width=80&height=80&name=HIPAA%20Compliant.png) Copyright © 2026 Congenica Ltd. Company number: 8273616 Registered in England and Wales.